Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
Covington
Medtronic
Cerilliant
Julphar
Citi
Chinese Patent Office
Fish and Richardson

Generated: August 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020895

« Back to Dashboard

NDA 020895 describes VIAGRA, which is a drug marketed by Pfizer Inc and is included in one NDA. It is available from eleven suppliers. There is one patent protecting this drug and two Paragraph IV challenges. Additional details are available on the VIAGRA profile page.

The generic ingredient in VIAGRA is sildenafil citrate. There are twenty drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 020895
Tradename:VIAGRA
Applicant:Pfizer Inc
Ingredient:sildenafil citrate
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 020895
Medical Subject Heading (MeSH) Categories for 020895
Suppliers and Packaging for NDA: 020895
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIAGRA sildenafil citrate TABLET;ORAL 020895 NDA Pfizer Laboratories Div Pfizer Inc 0069-4200 N 0069-4200-30
VIAGRA sildenafil citrate TABLET;ORAL 020895 NDA Pfizer Laboratories Div Pfizer Inc 0069-4210 N 0069-4210-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 25MG BASE
Approval Date:Mar 27, 1998TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Apr 22, 2020Product Flag?Substance Flag?Delist Request?Y

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 50MG BASE
Approval Date:Mar 27, 1998TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Apr 22, 2020Product Flag?Substance Flag?Delist Request?Y

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 100MG BASE
Approval Date:Mar 27, 1998TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Apr 22, 2020Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020895

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Inc VIAGRA sildenafil citrate TABLET;ORAL 020895-001 Mar 27, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Inc VIAGRA sildenafil citrate TABLET;ORAL 020895-003 Mar 27, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Inc VIAGRA sildenafil citrate TABLET;ORAL 020895-002 Mar 27, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Baxter
McKesson
Johnson and Johnson
Colorcon
Dow
US Army
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.